Birks Group (NYSE:BGI) Trading Down 0.9% – Here’s Why
Shares of Birks Group Inc. (NYSE: BGI - Get Free Report) traded down 0.9% on Thursday. The company traded as low as $0.68 and last traded at $0.6910. 3,912 shares were traded during mid-day trading, a decline of 88% from the average session volume of 33,686 shares. The stock had previously closed at $0.6975. Birks
BGI, Roche roll out diagnostic tests for Alzheimer's in China
BGI Genomics and Roche Diagnostics have rolled out tests for Alzheimer's disease in China, the companies said, in an effort to expand access to easier-to-use diagnosis and monitoring choices for patients with the brain-wasting condition.
'Terrifying': Why U.S. senator in top intel post wants more spying on Chinese companies
Chinese genomics company BGI has risen to prominence around the world but also has been subject to concerns about its gene sequencing and DNA collection practices. U.S. officials fear BGI's vast collection of global genomics data is not just intended for precision medicine but a strategic asset that could be used for the Chinese military or surveillance, including the development of a biotech-enabled "super soldier.
US bill to restrict business with China's WuXi AppTec, BGI passes House
The U.S. House of Representatives on Monday passed a bill that aims to restrict business with China's WuXi AppTec , BGI and several other biotech companies on national security grounds.
